United States Uterine Fibroid Industry Drivers:
United States Uterine Fibroid Industry – Overview
The United States Uterine Fibroid Industry is showing the significant growth; mainly due to change in lifestyle mainly dietary pattern, growing number of hysterectomy surgeries. Additionally rising in aging population also leads the Uterine Fibroid Industry with in this region. According to U.S. Department of Health and Human Services, study found that before 50s 70% of white and 80% of African Americans are diagnosed with fibroids. Also more than 200,000 hysterectomies are performed each year for uterine fibroids. Hysterectomies is the surgery that is used to remove the uterus, if the condition is painful.
AstraZeneca (U.K), Cook Medical Inc. (U.S.), Boston Scientific Corporation (U.S.), GE Healthcare (U.K), AbbVie Inc. (U.S.), Hologic (U.S.), CooperSurgical Inc. (U.S.), C. R. Bard, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), and Bayer AG (Germany) are some of the leading players at the cutting edge of the competition in the market of Uterine Fibroid.
Uterine fibroids Industry are the noncancerous growths of the uterus, which mostly appear during childbearing years. It is the abnormal growth of that gets developed inside or on the wall of a woman’s uterus. Uterine fibroids is also known as myomas or leiomyomas. The symptom of uterine fibroids are frequent urination, constipation, backache, heavy menstrual bleeding, pelvic pressure, or menstrual periods lasting more than a week. The women with mild symptoms may go for medical treatments such as hormonal drugs, gonadotropin agonists, progestin and oral contraceptives. Women with moderate to severe symptoms may need surgery to treat uterine fibroids. According to the U.S. Department of Health and Human Services office on Women Health, about 20% to 80% of women develop fibroids by the age of 50 and nearly 30% will get them at the age of 35. Uterine fibroids are most common in women in their 40s and early 50s.
United States Uterine Fibroid Industry - Regional Analysis
The market of Uterine Fibroid
devices is much higher in the United States region, owing to its high
prevalence in African- American race, change in lifestyle. According to one
large cohort study of NIS on African-American women in Maryland, uterine
fibroids was the cause of 65.4% of total 53,000 women undergoing hysterectomy.
Moreover, most of the major
market players belong from this region, thus they introduce the advance
technology firstly in the United States in comparison to others region.
About Market Research Future: MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients. In order to stay updated with technology
and work process of the industry, MRFR often plans & conducts meet with the
industry experts and industrial visits for its research analyst members.
Comments
Post a Comment